Literature DB >> 5882616

[Tracer studies with radioactive-labelled cyclophosphamide in brain tumors].

G Simon, E H Graul, H Hundeshagen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5882616     DOI： 10.1007/bf02074426

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN： 0001-6268            Impact factor:   2.216


× No keyword cloud information.
  2 in total

1.  A CONTRIBUTION TO THE PROBLEM OF TUMOUR SPECIFICITY OF CYCLOPHOSPHAMIDE; STUDIES WITH RADIO-ACTIVE ISOTOPES.

Authors:  H WILMANNS; H GRAUL; H HUNDESHAGEN; H ARNOLD
Journal:  Acta Unio Int Contra Cancrum       Date:  1964

2.  [Studies on the degradation, distribution and excretion of tritium-labelled cyclophosphamide in the human body. I. Distribution and excretion of the cytostatic which is labelled at different sites in the molecule].

Authors:  F RITZL; W BOLT; H NAHRMANN
Journal:  Klin Wochenschr       Date:  1962-08-15
  2 in total
  5 in total

1.  [PH determination in the brain and two-fold approach in the multiple-step cancer therapy concept. Possibilities of including the brain in the therapeutically tangible area of the body in multiple-step cancer therapy].

Authors:  M von Ardenne; P G Reitnauer
Journal:  Klin Wochenschr       Date:  1970-06-01

2.  [Ig-A-myeloma with cerebrospinal manifestation. Systematic localisation in pie mater and Virchow-Robin spaces, excessive increase of Ig-A in cerebrospinal fluid (author's transl)].

Authors:  W Dahlmann; F Grunwald
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974

3.  Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the rat.

Authors:  S Genka; J Deutsch; P L Stahle; U H Shetty; V John; C Robinson; S I Rapoport; N H Greig
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 4.  A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors.

Authors:  D J Stewart
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Chemotherapy of malignant gliomas: comparison of the effect of polychemo- and CCNU-therapy.

Authors:  W D Heiss
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.